Pneumonia

Pediatrics in Review

Volumn 34, Issue 10, 2013, Pages 438-456

  Gereige, Rani S ^a   Laufer, Pablo Marcelo ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFDINIR; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; INFLUENZA VACCINE; LEVOFLOXACIN; LINEZOLID; PENICILLIN DERIVATIVE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; TETRACYCLINE; VANCOMYCIN;

ABSCESS; ACTIVE IMMUNIZATION; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; BACTERIAL ARTHRITIS; BLOOD CULTURE; BRONCHOPLEURAL FISTULA; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; CYSTIC FIBROSIS; ENDOCARDITIS; HAND WASHING; HEMOLYTIC UREMIC SYNDROME; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; HYPONATREMIA; INFECTION CONTROL; INFECTION PREVENTION; LUNG ABSCESS; MENINGITIS; MYCOPLASMA PNEUMONIAE; NASOPHARYNGEAL ASPIRATION; NONHUMAN; OSTEOMYELITIS; PERICARDITIS; PERSONAL HYGIENE; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; PNEUMATOCELE; PNEUMONIA; PNEUMOTHORAX; REVIEW; SEROLOGY; SICKLE CELL ANEMIA; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORAX RADIOGRAPHY; WALKING PNEUMONIA;

ANTI-BACTERIAL AGENTS; BACTERIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; LUNG; PHYSICAL EXAMINATION; PNEUMONIA;

EID: 84888230282     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.34-10-438     Document Type: Review

References (31)

1. Ebell MH. Clinical diagnosis of pneumonia in children. Am Fam. Physician. 2010;82(2):192-193.
2. Puligandla PS, Laberge JM. Respiratory infections: pneumonia, lung abscess, and empyema. Semin Pediatr Surg. 2008;17(1):. 42-52.
3. Browne LR, Gorelick MH. Asthma and pneumonia. Pediatr. Clin North Am. 2010;57(6):1347-1356.
4. Schlaudecker EP, Frenck RW Jr. Adolescent pneumonia. Adolesc. Med State Art Rev. 2010;21(2):202-219, vii-viii.
5. Wilder RA. Question 1: are oral antibiotics as efficacious as. intravenous antibiotics for the treatment of community acquired. pneumonia? Arch Dis Child. 2011;96(1):103-104.
6. World Health Organization. Pneumonia. Fact sheet No. 331. April. 2013. http://www.who.int/mediacentre/factsheets/fs331/en/.
7. Shah S, Sharieff GQ. Pediatric respiratory infections. Emerg Med. Clin North Am. 2007;25(4):961-979, vi.
8. Esposito S, Principi N. Unsolved problems in the approach to. pediatric community-acquired pneumonia. Curr Opin Infect Dis. 2012;25(3):286-291.
9. Scott JA, Wonodi C, Moisi JC, et al Pneumonia Methods. Working Group. The Definition of pneumonia, the assessment of. severity, and clinical standardization in the Pneumonia Etiology. Research for Child Health study. Clin Infect Dis. 2012;54(Suppl. 2):S109-S116.
10. Lynch JP III, Zhanel GG. Streptococcus pneumoniae: epidemiology. and risk factors, evolution of antimicrobial resistance, and. impact of vaccines. Curr Opin Pulm Med. 2010;16(3):217-225.
11. Virkki R, Juven T, Rikalainen H, Svedström E, Mertsola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in. children. Thorax. 2002;57(5):438-441.
12. Nohynek H, Madhi S, Grijalva CG. Childhood bacterial. respiratory diseases: past, present, and future. Pediatr Infect Dis J. 2009;28(10 Suppl):S127-S132.
13. Prayle A, Atkinson M, Smyth A. Pneumonia in the developed. world. Paediatr Respir Rev. 2011;12(1):60-69.
14. Don M, Canciani M, Korppi M. Community-acquired pneumonia. in children: what's old? What's new? Acta Paediatr. 2010;99. (11):1602-1608.
15. Mulholland S, Gavranich JB, Gillies MB, Chang AB. Antibiotics. for community-acquired lower respiratory tract infections. secondary to Mycoplasma pneumoniae in children. Cochrane Database. Syst Rev. 2012;9(Issue 9):CD004875 10.1002/14651858.. CD00487.pub4.
16. Bradley JS, Byington CL, Shah SS, et al Pediatric Infectious. Diseases Society and the Infectious Diseases Society of America. Executive summary: the management of community-acquired. pneumonia in infants and children older than 3 months of age:. clinical practice guidelines by the Pediatric Infectious Diseases. Society and the Infectious Diseases Society of America. Clin Infect. Dis. 2011;53(7):617-630.
17. Shah VP, Tunik MG, Tsung JW. Prospective evaluation of. point-of-care ultrasonography for the diagnosis of pneumonia. in children and young adults. JAMA Pediatr. 2013;167(2):. 119-125.
18. Mularoni A, Furfaro E, Faraci M, et al. High Levels of b-Dglucan. in immunocompromised children with proven invasive. fungal disease. Clin Vaccine Immunol. 2010;17(5):882-883.
19. Hage CA, Knox KS, Davis TE, Wheat LJ. Antigen detection in. bronchoalveolar lavage fluid for diagnosis of fungal pneumonia. Curr Opin Pulm Med. 2011;17(3):167-171.
20. Boonsarngsuk V,Niyompattama A, Teosirimongkol C, Sriwanichrak. K. False-positive serum and bronchoalveolar lavage Aspergillus. galactomannan assays caused by different antibiotics. Scand J Infect. Dis. 2010;42(6-7):461-468.
21. Ranganathan SC, Sonnappa S. Pneumonia and other respiratory. infections. Pediatr Clin North Am. 2009;56(1):135-156, xi.
22. Chang CC, Cheng AC, Chang AB. Over-The-counter (OTC). medications to reduce cough as an adjunct to antibiotics for acute. pneumonia in children and adults. Cochrane Database Syst Rev. 2012;. 2(Issue 2):CD006088 10.1002/14651858.CD006088.pub3.
23. Lassi ZS, Haider BA, Bhutta ZA. Zinc supplementation for the. prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2010; (12, Issue 12)CD005978.10.1002/14651858.CD005978.pub2.
24. Yakoob MY, Theodoratou E, Jabeen A, et al. Preventive zinc. supplementation in developing countries: impact on mortality and. morbidity due to diarrhea, pneumonia and malaria. BMC Public. Health. 2011;11(Suppl 3):S23 http://www.biomedcentral.com/. 1471-2458/11/S3/S23.
25. Clifford V, Tebruegge M, Vandeleur M, Curtis N. Question 3:. can pneumonia caused by penicillin-resistant Streptococcus pneumoniae. be treated with penicillin? Arch Dis Child. 2010;95(1):73-77.
26. Sutijono D, Hom J, Zehtabchi S. Efficacy of 3-day versus 5-day. antibiotic therapy for clinically diagnosed nonsevere pneumonia in. children from developing countries. Eur J Emerg Med. 2011;18(5):. 244-250.
27. Gilchrist FJ. Is the use of chest physiotherapy beneficial in. children with community acquired pneumonia? Arch Dis Child. 2008;93(2):176-178.
28. Punpanich W, Groome M, Muhe L, Qazi SA, Madhi SA. Systematic review on the etiology and antibiotic treatment of. pneumonia in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2011;30(10):e192-e202.
29. Wonodi CB, Deloria-Knoll M, Feikin DR, et al; Pneumonia. Methods Working Group and PERCH Site Investigators. Evaluation. of risk factors for severe pneumonia in children: the Pneumonia. Etiology Research for Child Health study. Clin Infect Dis. 2012;54. (Suppl 2):S124-S131.
30. Chang AB, Chang CC, O'Grady K, Torzillo PJ. Lower. respiratory tract infections. Pediatr Clin North Am. 2009;56(6):. 1303-1321.
31. Esposito S, Cohen R, Domingo JD, et al. Do we know when, what, and for how long to treat? antibiotic therapy for communityacquired. pneumonia. Pediatr Infect Dis J. 2012;31(6):e78-e85.